Claims
- 1. A peptide comprising the following sequence:
- 2. A peptide as defined in claim 1, wherein R is a hydrogen atom.
- 3. A peptide as defined in claim 1, wherein R is propyl.
- 4. A peptide as defined in claim 1 wherein R is phenylpropyl.
- 5. An admixture comprising the peptide as defined in any one of claims 1 to 4 and a or more pharmaceutically acceptable carrier or excipients.
- 6. A pharmaceutical composition comprising from about 10 μg to about 100 mg of the peptide as defined in any one of claims 1 to 4 and a or more pharmaceutically acceptable carriers or excipients.
- 7. A method for treating or preventing diseases or conditions involving loss of bone mineral, comprising administering a therapeutically effective amount of the pharmaceutical composition as defined in claim 6 to a patient in need thereof.
- 8. The method of claim 7, wherein said diseases or conditions are selected from the group consisting of dental disease, osteoporosis and malignancy.
- 9. The method as defined in claim 8, wherein the loss of bone mineral is due to dental disease.
- 10. The method as defined in claim 8, wherein the loss of bone mineral is due to osteoporosis.
- 11. The method as defined in claim 8, wherein the loss of bone mineral is due to malignancy.
- 12. The method as defined in any one of claims 7 to 11, wherein said pharmaceutical composition effects replacement of bone mineral.
- 13. A peptide comprising the following sequence:
- 14. A peptide as defined in claim 13, wherein R is a hydrogen atom.
- 15. A peptide as defined in claim 13, wherein R is propyl.
- 16. A peptide as defined in claim 13, wherein R is phenylpropyl.
- 17. An admixture comprising the peptide as defined in any one of claims 13 to 17 and a or more pharmaceutically acceptable carriers or excipients.
- 18. A pharmaceutical composition comprising from about 10 μg to about 100 mg of the peptide as defined in any one of claims 13 to 17 and a or more pharmaceutically acceptable carriers or excipients.
- 19. A method for treating or preventing diseases or conditions involving loss of bone mineral, comprising administering a therapeutically effective amount of the pharmaceutical composition as defined in claim 18 to a patient in need thereof.
- 20. The method of claim 19, wherein said diseases or conditions are selected from the group consisting of dental disease, osteoporosis and malignancy.
- 21. The method as defined in claim 19, wherein the loss of bone mineral is due to dental disease.
- 22. The method as defined in claim 19, wherein the loss of bone mineral is due to osteoporosis.
- 23. The method as defined in claim 19, wherein the loss of bone mineral is due to malignancy.
- 24. The method as defined in any one of claims 19 to 23, wherein said pharmaceutical composition effects replacement of bone mineral.
- 25. A peptide as defined in claim 1, consisting of the following sequence:
- 26. A peptide as defined in claim 13, consisting of the following sequence:
Parent Case Info
[0001] The present invention claims benefit of priority to U.S. Provisional Serial No. 60/378,072, filed May 16, 2002, the entire contents of which is incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60378072 |
May 2002 |
US |